Apr 01, 2021 5:45pm EDT Vyant Bio Announces Investor Webcast to Provide Updates Post Merger between Cancer Genetics and StemoniX
Mar 25, 2021 9:15am EDT Cancer Genetics Announces Shareholder Approval of All Proposals in Connection with the Proposed Merger with StemoniX
Mar 18, 2021 8:30am EDT Cancer Genetics Announces Roland J. Carrillo, PhD as Vice President of Business Development
Mar 04, 2021 4:15pm EST Cancer Genetics to Present at the H.C. Wainwright Global Life Sciences Conference
Feb 16, 2021 4:45pm EST Cancer Genetics Announces Closing of $17.5 Million Common Stock Offering Priced At-the-Market under Nasdaq Rules
Feb 10, 2021 11:00pm EST Cancer Genetics Announces $17.5 Million Common Stock Offering Priced At-the-Market under Nasdaq Rules
Feb 01, 2021 5:16pm EST Cancer Genetics Announces Closing of $10.0 Million Private Placement Priced At-the-Market
